CLINICAL_TRIALS
research
· 2025-11-18
Clinical Trial Update: Natural History Study Protocol in PMM2-CDG (CDG-Ia)
Summary
This document describes a natural history study protocol for PMM2-CDG (phosphomannomutase 2 deficiency) sponsored by Glycomine, Inc., with status listed as acti…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Glycomine, Inc. | Conditions: Phosphomannomutase 2 Deficiency | Status: ACTIVE_NOT_RECRUITING